Mutations in the C-terminal region of the HIV-1 reverse transcriptase and their correlation with drug resistance associated mutations and antiviral treatment

被引：0
|
作者：
I Michels
S Staszewski
L Gürtler
G Nisius
A Müller
L Locher
H-W Doerr
M Stürmer
机构：
[1] Institute for Medical Virology,J.W.Goethe University Hospital
[2] Department of Internal Medicine II,J.W.Goethe University Hospital, Medical HIV Treatment and Research Unit
[3] Infektiologikum Frankfurt-Sachsenhausen,undefined
[4] Infektiologikum Frankfurt-City,undefined
来源：
European Journal of Medical Research | / 15卷
关键词：
antiretroviral therapy; genotypic resistance; reverse transcriptase; polymerase; RNase H; connection domain;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Should we include connection domain mutations of HIV-1 reverse transcriptase in HIV resistance testing?
    Gotte, Matthias
    PLOS MEDICINE, 2007, 4 (12) : 1858 - 1861
  • [32] Interactions of different drug resistance mutations in HIV Reverse Transcriptase in defining patterns of drug resistance
    Mark A Wainberg
    Retrovirology, 8 (Suppl 2)
  • [33] Development and Evaluation of a National Reference Panel of HIV-1 Protease and Reverse Transcriptase Drug-Resistance Mutations for HIV-1 Genotypic Resistance Assays in China
    Sihong Xu
    Jingyun Li
    Zuoyi Bao
    Hui Xing
    Ping Zhong
    Hanping Li
    Haiwei Zhou
    Xinping Li
    Sharon Wu
    Aijing Song
    Xiuhua Li
    Jianhui Nie
    Youchun Wang
    Molecular Diagnosis & Therapy, 2010, 14 : 31 - 41
  • [34] Primary HIV-1 drug resistance in the C-terminal domains of viral reverse transcriptase among drug-naive patients from Southern Brazil
    Santos, Andre F.
    Silveira, Jussara
    Muniz, Claudia P.
    Tornatore, Michele
    Goes, Livia R.
    Mendoza-Sassi, Raul A.
    Martinez, Ana M. B.
    Tupinambas, Unai
    Greco, Dirceu B.
    Soares, Marcelo A.
    JOURNAL OF CLINICAL VIROLOGY, 2011, 52 (04) : 373 - 376
  • [35] Development and Evaluation of a National Reference Panel of HIV-1 Protease and Reverse Transcriptase Drug-Resistance Mutations for HIV-1 Genotypic Resistance Assays in China
    Xu, Sihong
    Li, Jingyun
    Bao, Zuoyi
    Xing, Hui
    Zhong, Ping
    Li, Hanping
    Zhou, Haiwei
    Li, Xinping
    Wu, Sharon
    Song, Aijing
    Li, Xiuhua
    Niel, Jianhui
    Wang, Youchun
    MOLECULAR DIAGNOSIS & THERAPY, 2010, 14 (01) : 31 - 41
  • [36] Characterization of Nucleoside Reverse Transcriptase Inhibitor-Associated Mutations in the RNase H Region of HIV-1 Subtype C Infected Individuals
    Ngcapu, Sinaye
    Theys, Kristof
    Libin, Pieter
    Marconi, Vincent C.
    Sunpath, Henry
    Ndung'u, Thumbi
    Gordon, Michelle L.
    VIRUSES-BASEL, 2017, 9 (11):
  • [37] Selection of nonnucleoside reverse transcriptase inhibitor-associated mutations in HIV-1 subtype C: evidence of etravirine cross-resistance
    Neogi, Ujjwal
    Shet, Anita
    Shamsundar, Ranjani
    Ekstrand, Maria L.
    AIDS, 2011, 25 (08) : 1123 - 1126
  • [38] Effects of Mutations in the Connection and RNase H Domains of HIV-1 Reverse Transcriptase on Drug Susceptibility
    Ehteshami, Maryam
    Goette, Matthias
    AIDS REVIEWS, 2008, 10 (04) : 224 - 235
  • [39] HIV-1 Reverse Transcriptase Drug-Resistance Mutations in Chronically Infected Individuals Receiving or Naive to HAART in Cameroon
    Burda, Sherri T.
    Viswanath, Ragupathy
    Zhao, Jiangqin
    Kinge, Thompson
    Anyangwe, Christopher
    Tinyami, Erick T.
    Haldar, Bijayesh
    Powell, Rebecca L. R.
    Jarido, Veronica
    Hewlett, Indira K.
    Nyambi, Phillipe N.
    JOURNAL OF MEDICAL VIROLOGY, 2010, 82 (02) : 187 - 196
  • [40] Identification of RT mutations associated with HIV-1 drug resistance in treatment naive patients
    Magiorkinis, E
    Paraskevis, D
    Lazanas, M
    Kiosses, VG
    Gargalianos, P
    Hatzakis, A
    AIDS, 1998, 12 : S25 - S25
12345